Eintrag weiter verarbeiten
The feasibility, reliability and concurrent validity of the MSReactor computerized cognitive screening tool in multiple sclerosis
Gespeichert in:
| Zeitschriftentitel: | Therapeutic Advances in Neurological Disorders |
|---|---|
| Personen und Körperschaften: | , , , , |
| In: | Therapeutic Advances in Neurological Disorders, 12, 2019, S. 175628641985918 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
SAGE Publications
|
| Schlagwörter: |
| author_facet |
Merlo, Daniel Darby, David Kalincik, Tomas Butzkueven, Helmut van der Walt, Anneke Merlo, Daniel Darby, David Kalincik, Tomas Butzkueven, Helmut van der Walt, Anneke |
|---|---|
| author |
Merlo, Daniel Darby, David Kalincik, Tomas Butzkueven, Helmut van der Walt, Anneke |
| spellingShingle |
Merlo, Daniel Darby, David Kalincik, Tomas Butzkueven, Helmut van der Walt, Anneke Therapeutic Advances in Neurological Disorders The feasibility, reliability and concurrent validity of the MSReactor computerized cognitive screening tool in multiple sclerosis Neurology (clinical) Neurology Pharmacology |
| author_sort |
merlo, daniel |
| spelling |
Merlo, Daniel Darby, David Kalincik, Tomas Butzkueven, Helmut van der Walt, Anneke 1756-2864 1756-2864 SAGE Publications Neurology (clinical) Neurology Pharmacology http://dx.doi.org/10.1177/1756286419859183 <jats:sec><jats:title>Background:</jats:title><jats:p> Multiple sclerosis (MS) cognitive tests are resource intensive and limited by practice effects that prevent frequent retesting. Brief, reliable and valid monitoring tools are urgently needed to detect subtle, subclinical cognitive changes in people with MS. Cognitive monitoring over time could contribute to a new definition of disease progression, supplementing routine clinical monitoring. </jats:p></jats:sec><jats:sec><jats:title>Methods:</jats:title><jats:p> MSReactor is a web-based battery that measures psychomotor (processing) speed, visual attention and working memory, using simple reaction time tasks. Clinic-based tasks were completed at baseline and 6 monthly with home testing 1–3 monthly. Acceptability, quality of life, depression and anxiety surveys were completed. We studied its correlation with the Symbol Digit Modalities Test, practice effects, test–retest reliability and the discriminative ability of MSReactor. </jats:p></jats:sec><jats:sec><jats:title>Results:</jats:title><jats:p> A total of 450 people with MS were recruited over 18 months, with 81% opting to complete home-based testing. Most participants (96%) would be happy (or neutral) to repeat the tasks again and just four reported the tasks made them ‘very anxious’. Persistence of home testing was high and practice effects stabilized within three tests. MSReactor tasks correlated with Symbol Digit Modalities Test scores and participants with MS performed slower than healthy controls. </jats:p></jats:sec><jats:sec><jats:title>Conclusion:</jats:title><jats:p> MSReactor is a scalable and reliable cognitive screening tool that can be used in the clinic and remotely. MSReactor task performance correlated with another highly validated cognitive test, was sensitive to MS and baseline predictors of cognitive performance were identified. </jats:p></jats:sec> The feasibility, reliability and concurrent validity of the MSReactor computerized cognitive screening tool in multiple sclerosis Therapeutic Advances in Neurological Disorders |
| doi_str_mv |
10.1177/1756286419859183 |
| facet_avail |
Online Free |
| finc_class_facet |
Medizin Chemie und Pharmazie |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE3Ny8xNzU2Mjg2NDE5ODU5MTgz |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE3Ny8xNzU2Mjg2NDE5ODU5MTgz |
| institution |
DE-D275 DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 DE-Gla1 DE-Zi4 DE-15 DE-Rs1 DE-Pl11 DE-105 DE-14 DE-Ch1 DE-L229 |
| imprint |
SAGE Publications, 2019 |
| imprint_str_mv |
SAGE Publications, 2019 |
| issn |
1756-2864 |
| issn_str_mv |
1756-2864 |
| language |
English |
| mega_collection |
SAGE Publications (CrossRef) |
| match_str |
merlo2019thefeasibilityreliabilityandconcurrentvalidityofthemsreactorcomputerizedcognitivescreeningtoolinmultiplesclerosis |
| publishDateSort |
2019 |
| publisher |
SAGE Publications |
| recordtype |
ai |
| record_format |
ai |
| series |
Therapeutic Advances in Neurological Disorders |
| source_id |
49 |
| title |
The feasibility, reliability and concurrent validity of the MSReactor computerized cognitive screening tool in multiple sclerosis |
| title_unstemmed |
The feasibility, reliability and concurrent validity of the MSReactor computerized cognitive screening tool in multiple sclerosis |
| title_full |
The feasibility, reliability and concurrent validity of the MSReactor computerized cognitive screening tool in multiple sclerosis |
| title_fullStr |
The feasibility, reliability and concurrent validity of the MSReactor computerized cognitive screening tool in multiple sclerosis |
| title_full_unstemmed |
The feasibility, reliability and concurrent validity of the MSReactor computerized cognitive screening tool in multiple sclerosis |
| title_short |
The feasibility, reliability and concurrent validity of the MSReactor computerized cognitive screening tool in multiple sclerosis |
| title_sort |
the feasibility, reliability and concurrent validity of the msreactor computerized cognitive screening tool in multiple sclerosis |
| topic |
Neurology (clinical) Neurology Pharmacology |
| url |
http://dx.doi.org/10.1177/1756286419859183 |
| publishDate |
2019 |
| physical |
175628641985918 |
| description |
<jats:sec><jats:title>Background:</jats:title><jats:p> Multiple sclerosis (MS) cognitive tests are resource intensive and limited by practice effects that prevent frequent retesting. Brief, reliable and valid monitoring tools are urgently needed to detect subtle, subclinical cognitive changes in people with MS. Cognitive monitoring over time could contribute to a new definition of disease progression, supplementing routine clinical monitoring. </jats:p></jats:sec><jats:sec><jats:title>Methods:</jats:title><jats:p> MSReactor is a web-based battery that measures psychomotor (processing) speed, visual attention and working memory, using simple reaction time tasks. Clinic-based tasks were completed at baseline and 6 monthly with home testing 1–3 monthly. Acceptability, quality of life, depression and anxiety surveys were completed. We studied its correlation with the Symbol Digit Modalities Test, practice effects, test–retest reliability and the discriminative ability of MSReactor. </jats:p></jats:sec><jats:sec><jats:title>Results:</jats:title><jats:p> A total of 450 people with MS were recruited over 18 months, with 81% opting to complete home-based testing. Most participants (96%) would be happy (or neutral) to repeat the tasks again and just four reported the tasks made them ‘very anxious’. Persistence of home testing was high and practice effects stabilized within three tests. MSReactor tasks correlated with Symbol Digit Modalities Test scores and participants with MS performed slower than healthy controls. </jats:p></jats:sec><jats:sec><jats:title>Conclusion:</jats:title><jats:p> MSReactor is a scalable and reliable cognitive screening tool that can be used in the clinic and remotely. MSReactor task performance correlated with another highly validated cognitive test, was sensitive to MS and baseline predictors of cognitive performance were identified. </jats:p></jats:sec> |
| container_start_page |
0 |
| container_title |
Therapeutic Advances in Neurological Disorders |
| container_volume |
12 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792340282050609152 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T16:01:09.866Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=The+feasibility%2C+reliability+and+concurrent+validity+of+the+MSReactor+computerized+cognitive+screening+tool+in+multiple+sclerosis&rft.date=2019-01-01&genre=article&issn=1756-2864&volume=12&pages=175628641985918&jtitle=Therapeutic+Advances+in+Neurological+Disorders&atitle=The+feasibility%2C+reliability+and+concurrent+validity+of+the+MSReactor+computerized+cognitive+screening+tool+in+multiple+sclerosis&aulast=van+der+Walt&aufirst=Anneke&rft_id=info%3Adoi%2F10.1177%2F1756286419859183&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792340282050609152 |
| author | Merlo, Daniel, Darby, David, Kalincik, Tomas, Butzkueven, Helmut, van der Walt, Anneke |
| author_facet | Merlo, Daniel, Darby, David, Kalincik, Tomas, Butzkueven, Helmut, van der Walt, Anneke, Merlo, Daniel, Darby, David, Kalincik, Tomas, Butzkueven, Helmut, van der Walt, Anneke |
| author_sort | merlo, daniel |
| container_start_page | 0 |
| container_title | Therapeutic Advances in Neurological Disorders |
| container_volume | 12 |
| description | <jats:sec><jats:title>Background:</jats:title><jats:p> Multiple sclerosis (MS) cognitive tests are resource intensive and limited by practice effects that prevent frequent retesting. Brief, reliable and valid monitoring tools are urgently needed to detect subtle, subclinical cognitive changes in people with MS. Cognitive monitoring over time could contribute to a new definition of disease progression, supplementing routine clinical monitoring. </jats:p></jats:sec><jats:sec><jats:title>Methods:</jats:title><jats:p> MSReactor is a web-based battery that measures psychomotor (processing) speed, visual attention and working memory, using simple reaction time tasks. Clinic-based tasks were completed at baseline and 6 monthly with home testing 1–3 monthly. Acceptability, quality of life, depression and anxiety surveys were completed. We studied its correlation with the Symbol Digit Modalities Test, practice effects, test–retest reliability and the discriminative ability of MSReactor. </jats:p></jats:sec><jats:sec><jats:title>Results:</jats:title><jats:p> A total of 450 people with MS were recruited over 18 months, with 81% opting to complete home-based testing. Most participants (96%) would be happy (or neutral) to repeat the tasks again and just four reported the tasks made them ‘very anxious’. Persistence of home testing was high and practice effects stabilized within three tests. MSReactor tasks correlated with Symbol Digit Modalities Test scores and participants with MS performed slower than healthy controls. </jats:p></jats:sec><jats:sec><jats:title>Conclusion:</jats:title><jats:p> MSReactor is a scalable and reliable cognitive screening tool that can be used in the clinic and remotely. MSReactor task performance correlated with another highly validated cognitive test, was sensitive to MS and baseline predictors of cognitive performance were identified. </jats:p></jats:sec> |
| doi_str_mv | 10.1177/1756286419859183 |
| facet_avail | Online, Free |
| finc_class_facet | Medizin, Chemie und Pharmazie |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE3Ny8xNzU2Mjg2NDE5ODU5MTgz |
| imprint | SAGE Publications, 2019 |
| imprint_str_mv | SAGE Publications, 2019 |
| institution | DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Rs1, DE-Pl11, DE-105, DE-14, DE-Ch1, DE-L229 |
| issn | 1756-2864 |
| issn_str_mv | 1756-2864 |
| language | English |
| last_indexed | 2024-03-01T16:01:09.866Z |
| match_str | merlo2019thefeasibilityreliabilityandconcurrentvalidityofthemsreactorcomputerizedcognitivescreeningtoolinmultiplesclerosis |
| mega_collection | SAGE Publications (CrossRef) |
| physical | 175628641985918 |
| publishDate | 2019 |
| publishDateSort | 2019 |
| publisher | SAGE Publications |
| record_format | ai |
| recordtype | ai |
| series | Therapeutic Advances in Neurological Disorders |
| source_id | 49 |
| spelling | Merlo, Daniel Darby, David Kalincik, Tomas Butzkueven, Helmut van der Walt, Anneke 1756-2864 1756-2864 SAGE Publications Neurology (clinical) Neurology Pharmacology http://dx.doi.org/10.1177/1756286419859183 <jats:sec><jats:title>Background:</jats:title><jats:p> Multiple sclerosis (MS) cognitive tests are resource intensive and limited by practice effects that prevent frequent retesting. Brief, reliable and valid monitoring tools are urgently needed to detect subtle, subclinical cognitive changes in people with MS. Cognitive monitoring over time could contribute to a new definition of disease progression, supplementing routine clinical monitoring. </jats:p></jats:sec><jats:sec><jats:title>Methods:</jats:title><jats:p> MSReactor is a web-based battery that measures psychomotor (processing) speed, visual attention and working memory, using simple reaction time tasks. Clinic-based tasks were completed at baseline and 6 monthly with home testing 1–3 monthly. Acceptability, quality of life, depression and anxiety surveys were completed. We studied its correlation with the Symbol Digit Modalities Test, practice effects, test–retest reliability and the discriminative ability of MSReactor. </jats:p></jats:sec><jats:sec><jats:title>Results:</jats:title><jats:p> A total of 450 people with MS were recruited over 18 months, with 81% opting to complete home-based testing. Most participants (96%) would be happy (or neutral) to repeat the tasks again and just four reported the tasks made them ‘very anxious’. Persistence of home testing was high and practice effects stabilized within three tests. MSReactor tasks correlated with Symbol Digit Modalities Test scores and participants with MS performed slower than healthy controls. </jats:p></jats:sec><jats:sec><jats:title>Conclusion:</jats:title><jats:p> MSReactor is a scalable and reliable cognitive screening tool that can be used in the clinic and remotely. MSReactor task performance correlated with another highly validated cognitive test, was sensitive to MS and baseline predictors of cognitive performance were identified. </jats:p></jats:sec> The feasibility, reliability and concurrent validity of the MSReactor computerized cognitive screening tool in multiple sclerosis Therapeutic Advances in Neurological Disorders |
| spellingShingle | Merlo, Daniel, Darby, David, Kalincik, Tomas, Butzkueven, Helmut, van der Walt, Anneke, Therapeutic Advances in Neurological Disorders, The feasibility, reliability and concurrent validity of the MSReactor computerized cognitive screening tool in multiple sclerosis, Neurology (clinical), Neurology, Pharmacology |
| title | The feasibility, reliability and concurrent validity of the MSReactor computerized cognitive screening tool in multiple sclerosis |
| title_full | The feasibility, reliability and concurrent validity of the MSReactor computerized cognitive screening tool in multiple sclerosis |
| title_fullStr | The feasibility, reliability and concurrent validity of the MSReactor computerized cognitive screening tool in multiple sclerosis |
| title_full_unstemmed | The feasibility, reliability and concurrent validity of the MSReactor computerized cognitive screening tool in multiple sclerosis |
| title_short | The feasibility, reliability and concurrent validity of the MSReactor computerized cognitive screening tool in multiple sclerosis |
| title_sort | the feasibility, reliability and concurrent validity of the msreactor computerized cognitive screening tool in multiple sclerosis |
| title_unstemmed | The feasibility, reliability and concurrent validity of the MSReactor computerized cognitive screening tool in multiple sclerosis |
| topic | Neurology (clinical), Neurology, Pharmacology |
| url | http://dx.doi.org/10.1177/1756286419859183 |